Proteomics signature of autoimmune atrophic gastritis: towards a link with gastric cancer.
Autoimmune disease
Biological markers
Gastric cancer
Gastritis
Proteomics
Journal
Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
ISSN: 1436-3305
Titre abrégé: Gastric Cancer
Pays: Japan
ID NLM: 100886238
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
received:
31
07
2020
accepted:
09
12
2020
pubmed:
24
2
2021
medline:
21
12
2021
entrez:
23
2
2021
Statut:
ppublish
Résumé
Autoimmune atrophic gastritis (AAG) is a chronic disease that can progress to gastric cancer (GC). To better understand AAG pathology, this proteomics study investigated gastric proteins whose expression levels are altered in this disease and also in GC. Using two-dimensional difference gel electrophoresis (2D-DIGE), we compared protein maps of gastric corpus biopsies from AAG patients and controls. Differentially abundant spots (|fold change|≥ 1.5, P < 0.01) were selected and identified by LC-MS/MS. The spots were further assessed in gastric antrum biopsies from AAG patients (without and with Helicobacter pylori infection) and from GC patients and unaffected first-degree relatives of GC patients. 2D-DIGE identified 67 differentially abundant spots, with 28 more and 39 less abundant in AAG-corpus than controls. LC-MS/MS identified these as 53 distinct proteins. The most significant (adjusted P < 0.01) biological process associated with the less abundant proteins was "tricarboxylic acid cycle". Of the 67 spots, 57 were similarly differentially abundant in AAG-antrum biopsies irrespective of H. pylori infection status. The differential abundance was also observed in GC biopsies for 14 of 28 more abundant and 35 of 39 less abundant spots, and in normal gastric biopsies of relatives of GC patients for 6 and 25 spots, respectively. Immunoblotting confirmed the different expression levels of two more abundant proteins (PDIA3, GSTP gene products) and four less abundant proteins (ATP5F1A, PGA3, SDHB, PGC). This study identified a proteomics signature of AAG. Many differential proteins were shared by GC and may be involved in the progression of AAG to GC.
Sections du résumé
BACKGROUND
BACKGROUND
Autoimmune atrophic gastritis (AAG) is a chronic disease that can progress to gastric cancer (GC). To better understand AAG pathology, this proteomics study investigated gastric proteins whose expression levels are altered in this disease and also in GC.
METHODS
METHODS
Using two-dimensional difference gel electrophoresis (2D-DIGE), we compared protein maps of gastric corpus biopsies from AAG patients and controls. Differentially abundant spots (|fold change|≥ 1.5, P < 0.01) were selected and identified by LC-MS/MS. The spots were further assessed in gastric antrum biopsies from AAG patients (without and with Helicobacter pylori infection) and from GC patients and unaffected first-degree relatives of GC patients.
RESULTS
RESULTS
2D-DIGE identified 67 differentially abundant spots, with 28 more and 39 less abundant in AAG-corpus than controls. LC-MS/MS identified these as 53 distinct proteins. The most significant (adjusted P < 0.01) biological process associated with the less abundant proteins was "tricarboxylic acid cycle". Of the 67 spots, 57 were similarly differentially abundant in AAG-antrum biopsies irrespective of H. pylori infection status. The differential abundance was also observed in GC biopsies for 14 of 28 more abundant and 35 of 39 less abundant spots, and in normal gastric biopsies of relatives of GC patients for 6 and 25 spots, respectively. Immunoblotting confirmed the different expression levels of two more abundant proteins (PDIA3, GSTP gene products) and four less abundant proteins (ATP5F1A, PGA3, SDHB, PGC).
CONCLUSION
CONCLUSIONS
This study identified a proteomics signature of AAG. Many differential proteins were shared by GC and may be involved in the progression of AAG to GC.
Identifiants
pubmed: 33620602
doi: 10.1007/s10120-020-01148-3
pii: 10.1007/s10120-020-01148-3
pmc: PMC8064991
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
666-679Subventions
Organisme : Italian Minister of Health
ID : reference number RF-2016-02361525
Références
Lenti MV, Rugge M, Lahner E, Miceli E, Toh BH, Genta RM, et al. Autoimmune gastritis. Nat Rev Dis Primers. 2020;6:56.
pubmed: 32647173
Di Sabatino A, Lenti MV, Giuffrida P, Vanoli A, Corazza GR. New insights into immune mechanisms underlying autoimmune diseases of the gastrointestinal tract. Autoimmun Rev. 2015;14:1161–9.
pubmed: 26275585
Mårdh S, Song YH. Characterization of antigenic structures in auto-immune atrophic gastritis with pernicious anaemia. The parietal cell H, K-ATPase and the chief cell pepsinogen are the two major antigens. Acta Physiol Scand. 1989;136:581–7.
pubmed: 2528890
Lahner E, Norman GL, Severi C, Encabo S, Shums Z, Vannella L, et al. Reassessment of intrinsic factor and parietal cell autoantibodies in atrophic gastritis with respect to cobalamin deficiency. Am J Gastroenterol. 2009;104:2071–9.
pubmed: 19491828
Chlumska A, Boudova L, Benes Z, Zámecník M. Autoimmune gastritis. A clinicopathologic study of 25 cases. Cesk Patol. 2005;41(4):137–42.
pubmed: 16382988
Solcia E, Fiocca R, Villani L, Luinetti O, Capella C. Hyperplastic, dysplastic, and neoplastic enterochromaffin-like-cell proliferations of the gastric mucosa. Classification and histogenesis. Am J Surg Pathol. 1995;19:S1–7.
pubmed: 7762735
Carmel R. Pepsinogens and other serum markers in pernicious anemia. Am J Clin Pathol. 1988;90:442–5.
pubmed: 3177265
Rusak E, Chobot A, Krzywicka A, Wenzlau J. Anti-parietal cell antibodies—diagnostic significance. Adv Med Sci. 2016;61:175–9.
pubmed: 26918709
Khan S, Del-Duca C, Fenton E, Holding S, Hirst J, Doré PC, et al. Limited value of testing for intrinsic factor antibodies with negative gastric parietal cell antibodies in pernicious anaemia. J Clin Pathol. 2009;62:439–41.
pubmed: 19398595
Magris R, De Re V, Maiero S, Fornasarig M, Guarnieri G, Caggiari L, et al. Low pepsinogen I/II ratio and high gastrin-17 levels typify chronic atrophic autoimmune gastritis patients with gastric neuroendocrine tumors. Clin Transl Gastroenterol. 2020;11:e00238.
pubmed: 33094954
pmcid: 7494140
Miceli E, Padula D, Lenti MV, Gallia A, Albertini R, Di Stefano M, et al. A laboratory score in the diagnosis of autoimmune atrophic gastritis: a prospective study. J Clin Gastroenterol. 2015;49:e1–5.
pubmed: 24583750
Strickland RG. Gastritis. In: Van der Reis L, editor. Immune disorders. Front Gastrointest Res. Basel: Karger; 1975. p. 12–8.
Strickland RG, Mackay IR. A reappraisal of the nature and significance of chronic atrophic gastritis. Am J Dig Dis. 1973;18:426–40.
pubmed: 4573514
Veijola LI, Oksanen AM, Sipponen PI, Rautelin HI. Association of autoimmune type atrophic corpus gastritis with Helicobacter pylori infection. World J Gastroenterol. 2010;16:83–8.
pubmed: 20039453
pmcid: 2799921
Miceli E, Vanoli A, Lenti MV, Klersy C, Di Stefano M, Luinetti O. Natural history of autoimmune atrophic gastritis: a prospective, single centre, long-term experience. Aliment Pharmacol Ther. 2019;50:1172–80.
pubmed: 31621927
Bizzaro N, Antico A, Villalta D. Autoimmunity and Gastric Cancer. Autoimmune gastritis has been associated with the development of two types of gastric neoplasms: intestinal type and type I gastric carcinoid. Int J Mol Sci. 2018;19(2):pii: E377.
Lahner E, Esposito G, Galli G, Annibale B. Atrophic gastritis and pre-malignant gastric lesions. Transl Gastrointest Cancer. 2015;4:272–81.
Kokkola A, Sjoblom SM, Haapiainen R, Sipponen P, Puolakkainen P, Järvinen H. The risk of gastric carcinoma and carcinoid tumours in patients with pernicious anaemia. A prospective follow-up study. Scand J Gastroenterol. 1998;33:88–92.
pubmed: 9489914
Kodama M, Murakami K, Okimoto T, Abe H, Sato R, Ogawa R, et al. Histological characteristics of gastric mucosa prior to Helicobacter pylori eradication may predict gastric cancer. Scand J Gastroenterol. 2013;48:1249–56.
pubmed: 24079881
Vannella L, Lahner E, Osborn J, Bordi C, Miglione M, Delle Fave G, et al. Risk factors for progression to gastric neoplastic lesions in patients with atrophic gastritis. Aliment Pharmacol Ther. 2010;31:1042–50.
pubmed: 20175768
Minalyan A, Benhammou JN, Artashesyan A, Lewis MS, Pisegna JR. Autoimmune atrophic gastritis: current perspectives. Clin Exp Gastroenterol. 2017;10:19–27.
pubmed: 28223833
pmcid: 5304992
Toh BH. Diagnosis and classification of autoimmune gastritis. Autoimmun Rev. 2014;13:459–62.
pubmed: 24424193
Kondo T. Cancer biomarker development and two-dimensional difference gel electrophoresis (2D-DIGE). Biochim Biophys Acta Proteins Proteom. 2019;1867:2–8.
pubmed: 30392560
Wu JY, Cheng CC, Wang JY, Wu DC, Hsieh JS, Lee SC, et al. Discovery of tumor markers for gastric cancer by proteomics. PLoS ONE. 2014;9:e84158.
pubmed: 24404153
pmcid: 3880290
Zhang J, Song MQ, Zhu JS, Zhou Z, Xu ZP, Chen WX, et al. Identification of differentially-expressed proteins between early submucosal non-invasive and invasive colorectal cancer using 2D-DIGE and mass spectrometry. Int J Immunopathol Pharmacol. 2011;24:849–59.
pubmed: 22230392
Moriggi M, Pastorelli L, Torretta E, Tontini GE, Capitanio D, Bogetto SF, et al. Contribution of extracellular matrix and signal mechanotransduction to epithelial cell damage in inflammatory bowel disease patients: a proteomic study. Proteomics. 2017;17.
Song M, Camargo MC, Weinstein SJ, Best AF, Männistö S, Albanes D, Rabkin CS. Family history of cancer in first-degree relatives and risk of gastric cancer and its precursors in a Western population. Gastric Cancer. 2018;21:729–37.
pubmed: 29455268
pmcid: 7380686
Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996;20:1161–81.
pubmed: 8827022
Lauren P. The two histologic main types of gastric carcinoma: diffuse and so-called intestinal type carcinoma. An attempt at a histo-clinical classification. Acta Parhol Microbid Scan. 1965;64:31–49.
Di Sabatino A, Biagi F, Lenzi M, Frulloni L, Lenti MV, Giuffrida P, et al. Clinical usefulness of serum antibodies as biomarkers of gastrointestinal and liver diseases. Dig Liver Dis. 2017;49:947–56.
pubmed: 28733178
da Huang W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44–57.
Gruno M, Peet N, Tein A, Salupere R, Sirotkina M, Valle J, et al. Atrophic gastritis: deficient complex I of the respiratory chain in the mitochondria of corpus mucosal cells. J Gastroenterol. 2008;43:780–8.
pubmed: 18958547
Oexle H, Gnaiger E, Weiss G. Iron-dependent changes in cellular energy metabolism: influence on citric acid cycle and oxidative phosphorylation. Biochim Biophys Acta. 1999;1413:99–107.
pubmed: 10556622
Betesh AL, Santa Ana CA, Cole JA, Fordtran JS. Is achlorhydria a cause of iron deficiency anemia? Am J Clin Nutr. 2015;102:9–19.
pubmed: 25994564
Bergman MP, Vandenbroucke-Grauls CM, Appelmelk BJ, D’Elios MM, Amedei A, Azzurri A, et al. The story so far: Helicobacter pylori and gastric autoimmunity. Int Rev Immunol. 2005;24:63–91.
pubmed: 15763990
Zhang Y, Baig E, Williams DB. Functions of ERp57 in the folding and assembly of major histocompatibility complex class I molecules. J Biol Chem. 2006;281:14622–31.
pubmed: 16567808
Shimoda T, Wada R, Kure S, Ishino K, Kudo M, Ohashi R, et al. Expression of protein disulfide isomerase A3 and its clinicopathological association in gastric cancer. Oncol Rep. 2019;41:2265–72.
pubmed: 30720117
Coe H, Michalak M. ERp57, a multifunctional endoplasmic reticulum resident oxidoreductase. Int J Biochem Cell Biol. 2010;42:796–9.
pubmed: 20079872
Cicchillitti L, Di Michele M, Urbani A, Ferlini C, Donat MB, Scambia G, et al. Comparative proteomic analysis of paclitaxel sensitive A2780 epithelial ovarian cancer cell line and its resistant counterpart A2780TC1 by 2D-DIGE: the role of ERp57. J Proteome Res. 2009;8:1902–12.
pubmed: 19714814
Nomura S, Yamaguchi H, Ogawa M, Wang TC, Lee JR, Goldenring JR. Alterations in gastric mucosal lineages induced by acute oxyntic atrophy in wild-type and gastrin-deficient mice. Am J Physiol Gastrointest Liver Physiol. 2005;288:G362–75.
pubmed: 15647607
Lee JR, Baxter TM, Yamaguchi H, Wang TC, Goldenring JR, Anderson MG. Differential protein analysis of spasomolytic polypeptide expressing metaplasia using laser capture microdissection and two-dimensional difference gel electrophoresis. Appl Immunohistochem Mol Morphol. 2003;11:188–93.
pubmed: 12778007
Leys CM, Nomura S, LaFleur BJ, Ferrone S, Kaminishi M, Montgomery E, et al. Expression and prognostic significance of prothymosin-alpha and ERp57 in human gastric cancer. Surgery. 2007;141:41–50.
pubmed: 17188166
Singh S. Cytoprotective and regulatory functions of glutathione S-transferases in cancer cell proliferation and cell death. Cancer Chemoth Pharm. 2015;75:1–15.
Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol. 2005;45:51–88.
pubmed: 15822171
Suzuki H, Nishizawa T, Tsugawa H, Mogami S, Hibi T. Roles of oxidative stress in stomach disorders. J Clin Biochem Nutr. 2012;50:35–9.
pubmed: 22247598
Vigneron N, van den Eynde BJ. Proteasome subtypes and regulators in the processing of antigenic peptides presented by class I molecules of the major histocompatibility complex. Biomolecules. 2014;4:994–1025.
pubmed: 25412285
pmcid: 4279167
Junge W, Nelson N. ATP synthase. Annu Rev Biochem. 2015;84:631–57.
pubmed: 25839341
Gritti I, Banfi G, Roi GS. Pepsinogens: physiology, pharmacology pathophysiology and exercise. Pharmacol Res. 2000;41:265–81.
pubmed: 10675278
Kuipers EJ, Peña AS, Crusius JB, Defize J, van der Stoop P, Meuwissen SG, Pals G. Absence of pepsinogen A3 gene expression in the gastric mucosa of patients with gastric cancer. J Clin Pathol. 1995;48:376–9.
pubmed: 7615861
pmcid: 502560
Ning PF, Liu HJ, Yuan Y. Dynamic expression of pepsinogen C in gastric cancer, precancerous lesions and Helicobacter pylori associated gastric diseases. World J Gastroenterol. 2005;11:2545–8.
pubmed: 15849808
pmcid: 4305740
Rutter J, Winge DR, Schiffman JD. Succinate dehydrogenase—assembly, regulation and role in human disease. Mitochondrion. 2010;10:393–401.
pubmed: 20226277
pmcid: 2874626
Fernández-Coto DL, Gil J, Hernández A, Herrera-Goepfert R, Castro-Romero I, Hernández-Márquez E, et al. Quantitative proteomics reveals proteins involved in the progression from non-cancerous lesions to gastric cancer. J Proteomics. 2018;186:15–27.
pubmed: 30048774